Understand Business Like AI

Training Example: VYNDAMAX (Pfizer) – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

VYNDAMAX (Pfizer)

(https://vyndaqel.com) 📸 Data Snapshot: June 20, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE VYNDAMAX® (tafamidis) Prescription Treatment for ATTR-CM | Safety Info (https://vyndaqel.com)
Title

VYNDAMAX® (tafamidis) Prescription Treatment for ATTR-CM | Safety Info

Meta

VYNDAMAX® is used to treat wild-type & hereditary forms of transthyretin amyloid cardiomyopathy (ATTR-CM) in adults. Learn more about the risks and benefits.

H2 Top Menu
H2 Top Menu
H2 Main Menu
H2 Top Menu
H2 Main Menu
H2 Hear from VYNDAMAX patient Jack Nicklaus
H2 Hear from VYNDAMAX patient Jack Nicklaus
H2 VYNDAMAX is used to treat adults with wild-type or hereditary ATTR-CM to reduce death and hospitalization related to heart problems.
H2 #1 PRESCRIBED ATTR-CM treatment
H2 Clinical experience since approval
H2 Looking for information about VYNDAQEL® (tafamidis meglumine)? Find it here.
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H3 Watch how VYNDAMAX can help you
H3 – JacK Nicklaus, a real patient with ATTR-CM taking VYNDAMAX
H3 – JacK Nicklaus, a real patient with ATTR-CM taking VYNDAMAX
H3 – JacK Nicklaus, a real patient with ATTR-CM taking VYNDAMAX
H3 – JacK Nicklaus, a real patient with ATTR-CM taking VYNDAMAX
H3 Pfizer Patient Access Coordinator (PAC)
H3 Pfizer Patient Access Coordinator (PAC)
H3 Pfizer Patient Access Coordinator (PAC)
H3 You are now leaving VYNDAMAX.com.
H3 You are now leaving VYNDAMAX.com.
H3 Indication
NAV_HEADER_HEADING_REPEATED_BODY Jack Nicklaus’ ATTR‑CM Journey | VYNDAMAX® (tafamidis) | Safety Info (https://vyndaqel.com/jacks-journey/)
Title

Jack Nicklaus’ ATTR‑CM Journey | VYNDAMAX® (tafamidis) | Safety Info

Meta

Learn about golf legend Jack Nicklaus' ATTR‑CM journey, common red flags, and when it may be time to talk to a doctor.

H2 Top Menu
H2 Top Menu
H2 Main Menu
H2 Top Menu
H2 Main Menu
H2 Main Menu
H2 From red flags to diagnosis: Discover golf legend Jack Nicklaus’ ATTR-CM journey
H2 From red flags to diagnosis: Discover golf legend Jack Nicklaus’ ATTR-CM journey
H2 Main Menu
H2 Common red flags related to the heart:
H2 Understanding the ATTR-CM journey
H2 Find a heart specialist
H2 Find a Doctor Terms and Conditions
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H3 Jack's ATTR-CM Journey
H3 Jack's ATTR-CM Journey
H3 See a heart specialist when you start experiencing symptoms. If you think you may have ATTR-CM, it may be time to find a heart specialist near you.
H3 PLEASE PROVIDE THE INFORMATION BELOW TO RECEIVE YOUR TREATMENT DISCUSSION GUIDE.
H3 YOUR TREATMENT DISCUSSION GUIDE HAS BEEN SENT!
H3 You are now leaving VYNDAMAX.com
H3 You are now leaving VYNDAMAX.com
H3 Indication
H4 Red flags:
H4 In 2015, Jack started to have shortness of breath. It wouldn't go away and became impossible to ignore.
H4 “If you have shortness of breath, AFib, carpal tunnel, back pain you can't explain-go see your cardiologist.”
H5 – Jack, a real patient with ATTR-CM taking VYNDAMAX
NAV_HEADER_HEADING_REPEATED_BODY Financial Assistance | VYNDAMAX® (tafamidis) | Safety Info (https://vyndaqel.com/financial-assistance/)
Title

Financial Assistance | VYNDAMAX® (tafamidis) | Safety Info

Meta

Find support options such as connecting with a Patient Access Coordinator (PAC) or signing up for VyndaLink™, a resource that provides financial assistance options and support. T&C apply.

H2 Top Menu
H2 Top Menu
H2 Main Menu
H2 Top Menu
H2 Main Menu
H2 Main Menu
H2 Get support along your medication access journey
H2 Get support along your medication access journey
H2 Main Menu
H2 Connect with a Patient Access Coordinator (PAC)
H2 Sometimes an insurance plan will ask for a reauthorization after some time on treatment
H2 Learn more about 2026 Medicare Part D changes
H2 VynAssist – your home for personalized access and reimbursement support for patients prescribed VYNDAMAX.
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H3 Download the Medicare Part D Flashcard to learn more about what’s new in 2026
H3 You are now leaving VYNDAMAX.com
H3 You are now leaving VYNDAMAX.com
H3 Indication
H4 VYNDAMAX Co-pay Savings Program
H6 If that happens, you and your doctor can work together to give your insurance provider what they need, so you can continue VYNDAMAX.
NAV_HEADER_HEADING_REPEATED How May VYNDAMAX® (tafamidis) Help ATTR-CM? | Safety Info (https://vyndaqel.com/about-vyndamax/)
Title

How May VYNDAMAX® (tafamidis) Help ATTR-CM? | Safety Info

Meta

VYNDAMAX® can potentially reduce death and heart related hospitalizations in adults with ATTR-CM. Learn about the associated risks and benefits of treatment.

H2 Top Menu
H2 Top Menu
H2 Main Menu
H2 Top Menu
H2 Main Menu
H2 Main Menu
H2 Live longer. It's possible.
H2 Live longer. It's possible.
H2 Main Menu
H2 VYNDAMAX helps people with transthyretin cardiac amyloidosis (ATTR-CM) live longer
H2 VYNDAMAX was proven to reduce hospitalizations for heart problems
H2 Health-related quality-of-life measures†
H2 Heart function and exercise capacity were measured in patients taking VYNDAMAX
H2 VYNDAMAX is a treatment with a Class 1§ recommendation for ATTR-CM in guidelines from:
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H2 IMPORTANT SAFETY INFORMATION AND INDICATION
H3 Better quality of life
H3 Fewer heart-related symptoms
H3 More comfort performing daily activities
H3 Watch how VYNDAMAX can help you
H3 Hear from Stan, a real patient taking VYNDAMAX
H3 Hear from Stan, a real patient taking VYNDAMAX
H3 Hear from Stan, a real patient taking VYNDAMAX
H3 You are now leaving VYNDAMAX.com
H3 You are now leaving VYNDAMAX.com
H3 Indication
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://vyndaqel.com) VYNDAMAX® (tafamidis) Prescription Treatment for ATTR-CM | Safety Info 
[IMG: Actor portrayal of family at daughter]

[IMG: Actor portrayal of family at daughter]

[H2] Hear from VYNDAMAX patient Jack Nicklaus

[IMG: livelonger]

Golf legend, Jack Nicklaus
VYNDAMAX patient

See Jack's Story

[IMG: Actor portrayal of family at daughter]

[IMG: Actor portrayal of family at daughter]

[IMG: livelonger]

Actor portrayal

Previous

Next

[IMG: Actor portrayal of family at daughter]

[H2] Hear from VYNDAMAX patient Jack Nicklaus

[IMG: livelonger]

Golf legend, Jack Nicklaus
VYNDAMAX patient

See Jack's Story

[IMG: Actor portrayal of family at daughter]

[IMG: livelonger]

Actor portrayal

Previous

Next

[H2] VYNDAMAX is used to treat adults with wild-type or hereditary ATTR-CM to reduce death and hospitalization
related to heart problems.

[H3]
Watch how VYNDAMAX can help you

“Getting diagnosed took years so I'm spreading the word about the common red flags: A-Fib, shortness of breath, heart failure, and carpal tunnel syndrome.”
[H3] - JacK Nicklaus, a real patient with ATTR-CM taking VYNDAMAX
Hear more from Jack

“Getting diagnosed took years so I'm spreading the word about the common red flags: A-Fib, shortness of breath, heart failure, and carpal tunnel syndrome.”
[H3] - JacK Nicklaus, a real patient with ATTR-CM taking VYNDAMAX
Hear more from Jack

“Getting diagnosed took years so I'm spreading the word about the common red flags: A-Fib, shortness of breath, heart failure, and carpal tunnel syndrome.”
[H3] - JacK Nicklaus, a real patient with ATTR-CM taking VYNDAMAX
Hear more from Jack

“Getting diagnosed took years so I'm spreading the word about the common red flags: A-Fib, shortness of breath, heart failure, and carpal tunnel syndrome.”
[H3] - JacK Nicklaus, a real patient with ATTR-CM taking VYNDAMAX
Hear more from Jack

[IMG: PAC]

[H3] Pfizer Patient Access Coordinator (PAC)
Prescribed VYNDAMAX? A PAC is here to help get your prescription filled. Connect with a PAC today at 1-888-863-1177 (Mon-Fri, 8AM - 7PM ET).

Request a PAC

[IMG: PAC]

[H3] Pfizer Patient Access Coordinator (PAC)
Prescribed VYNDAMAX? A PAC is here to help get your prescription filled. Connect with a PAC today at 1-888-863-1177 (Mon-Fri, 8AM - 7PM ET).

[H3] Pfizer Patient Access Coordinator (PAC)
Prescribed VYNDAMAX? A PAC is here to help get your prescription filled. Connect with a PAC today at 1-888-863-1177 (Mon-Fri, 8AM - 7PM ET).

Request a PAC

[IMG: Vyndacares logo, a program that provides helpful information about ATTR-CM and VYNDAMAX (tafamidis). See safety info.]
Get to the heart of what matters

Stay informed with educational materials about ATTR-CM and VYNDAMAX

Sign up

[H2] Looking for information about VYNDAQEL® (tafamidis meglumine)? Find it here.

[H3] You are now leaving VYNDAMAX.com.
Links to other websites are provided as a convenience to the viewer. Pfizer accepts no responsibility for the content of linked sites.

[H3] You are now leaving VYNDAMAX.com.
The information provided in this website is intended only for healthcare professionals in the United States.

[H3] Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
3593 chars
SUB-PAGE (https://vyndaqel.com/jacks-journey/) Jack Nicklaus’ ATTR‑CM Journey | VYNDAMAX® (tafamidis) | Safety Info 
“If you recognize any of these red flags, ask your doctor about ATTR-CM and VYNDAMAX.”
- Jack, a real patient with ATTR-CM taking VYNDAMAX

[H3]
Jack's ATTR-CM Journey

Video transcript

Jack: Well my name is Jack Nicklaus and I used to be a professional golfer. I’ve won a couple of golf tournaments and I’ve designed a few golf courses. Well, I’m 86 years old. My wife Barbara and I, we’ve been married 65 years. We have 5 children, we have 24 grandchildren and 9 great-grandchildren. All my life, I've played sports and, you know, particularly golf. And if I happened to have a problem, I fixed it. And if I happen to have an injury from golf, I fixed it. I had a problem, nobody could figure out what it was, nor could I figure out what it was. Close to 10 years ago, first thing I really experienced was shortness of breath.
Nan: He really could walk maybe, you know, 10 to 15 feet and he'd have to stop to catch his breath and we're all like, “Come on, Dad. You’re in good shape!” You know?
Gary: Sometimes you can just attribute it to age, and as you’re kids, you know, when you're growing up, your dad's Superman. So, when you see, you know, your idol starting to kind of slow down, it's hard to watch.
Jack: My hands started to hurt at times. And back pain that you can't explain. I wanted to find out what the answer was. It didn't make any sense to me. I was going to get to the bottom of it.
GARY: He went to specialists all over the country. I mean, you can imagine that Jack Nicklaus has access to the best doctors in the world, and it wasn't until he had a routine endoscopy and his GI doctor said, “you have amyloids.”
Jack: And so my heart doctor contacted an amyloid specialist, we ran some more tests, and he says, “You have what we call ATTR-CM.” It turned out it's a rare progressive disease. But I finally found out what in the world I had. I never gave up in any event, whatever I played in, and certainly wasn't going to give up on life.
Gary: And now we have the diagnosis, we know what he has to do.
Jack: Well, I was diagnosed about six years ago. My cardiologist recommended that I take VYNDAMAX. So, a little over five years ago I started VYNDAMAX. Haven't missed a day, shouldn't miss a day and I’ve had no side effects.
Voice over: VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild type or hereditary transthyretin mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
Gary: Since my dad has been taking VYNDAMAX, his progression has slowed down.
Jack: It won't cure this situation, but it will slow it down. Thank goodness for VYNDAMAX. I see my kids quite often. I work with them in business. I designed golf courses and still very active in doing that. If I had to live the rest of my life the way I am, I have no problem with that.
Gary: He just played golf with all of his kids and grandkids and the great grandkids aren't playing golf yet, but they will be soon.
Nan: The grandkids are just starting with T-ball.
Jack: Now, they're starting T-ball.
Jack Jr.: I think he's always considered his real majors to be family. Publicly, it's the golf events, but I think if you really talk to mom and dad, they would emphasize family.
Jack: we love watching them participate and play and love being part of our grandkids’ life. The neat part about being part of their life is that they make us part of their life.
Gary: We hope my dad's message encourages people that are experiencing red flags to go to their cardiologist and rule out ATTR-CM.
Jack: If you have any of the symptoms that I've had, which was the shortness of breath, or AFib, or carpal tunnel, or back pain, you know, go see your cardiologist. If that happens to be your problem, you want to find out about it sooner rather than later. I am quite happy with what’s going on with my life today. I’m enjoying it, I’m living it, and thanks to VYNDAMAX, I’m able to do that.
Voice over: Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you have liver problems, are pregnant, or plan to become pregnant, are breastfeeding or plan to breastfeed. Tell your healthcare provider about all the medicines you take, including any prescription or over-the-counter medicines, vitamins and herbal supplements. There were no known side effects that happened during treatment with VYNDAMAX.

[H4] Red flags:
[H4] In 2015, Jack started to have shortness of breath. It wouldn't go away and became impossible to ignore.
[H4] “If you have shortness of breath, AFib, carpal tunnel, back pain you can't explain-go see your cardiologist.”
[H5] - Jack, a real patient with
ATTR-CM taking VYNDAMAX

[H2] Common red flags related to the heart:
[IMG: Icon of a heart pointing to atrial fibrillation, a heart-related symptom of ATTR-CM]
Afib
[IMG: Icon representing shortness of breath, a symptom that may be associated with ATTR‑CM]
Shortness of breath

Common red flags that seem unrelated to the heart:

[IMG: Icon representing carpal tunnel syndrome, a symptom that may be associated with ATTR‑CM]
Carpal tunnel syndrome
[IMG: Icon representing lower back pain, a symptom that may be associated with ATTR‑CM]
Lower back pain
[IMG: Icon representing stomach issues, a symptom that may be associated with ATTR‑CM]
Stomach issues
[IMG: Icon representing tingling or pain in the toes or feet, a symptom that may be associated with ATTR‑CM]
Strange tingling or pain in toes or feet

[H2] Understanding the ATTR-CM journey
Many people will see an average of 5 doctors before receiving an ATTR-CM diagnosis, so it’s important to let your healthcare provider know as soon as possible if you notice any signs or symptoms related to ATTR-CM

[H2] Find a heart specialist

Search

Close

[H2] Find a Doctor Terms and Conditions
Pfizer Inc. is providing this tool with a third party, Doctor.com, to help patients find physicians in their area who have experience with prescription treatments for ATTR-CM. While the directory is updated regularly, the search results may not include current physician information or a comprehensive list of all physicians who treat ATTR-CM. If you are a cardiologist and would like your listing to be added, updated, or removed, please contact Doctor.com.
No fees have been received by Pfizer Inc. or paid to physicians for inclusion in this directory. Inclusion of a physician in this directory does not represent an endorsement by or a recommendation from Pfizer Inc., nor does it imply that the physicians on the list will determine that treatment is right for you. You are ultimately responsible for the selection of a physician, and it is an important decision that you should consider carefully. This tool is just one source of information available to you.
Doctor.com may have its own terms of service and privacy policy for which Pfizer Inc. has no responsibility. Pfizer Inc. and Doctor.com do not collect patient- or physician-level data from this tool.

[IMG: VyndaCares logo, a program that provides helpful information about ATTR-CM and VYNDAMAX (tafamidis) | Safety Info]
Get to the heart of what matters

Stay informed with educational materials about ATTR-CM and VYNDAMAX

Sign up

Learn more about Jack and VYNDAMAX
Page last updated: 4/6/2026

[H3]
PLEASE PROVIDE THE INFORMATION BELOW TO RECEIVE YOUR TREATMENT DISCUSSION GUIDE.
Recipient Email Address
Privacy Statement
Pfizer understands your personal and health information is private. The email address provided above will only be used to send the requested discussion guide. As a reminder, any individual information you enter about yourself in the discussion guide will only be viewed in the aggregate with other collected responses.

By checking this box, I agree that I am 18 years of age or older.

[H3]
YOUR TREATMENT DISCUSSION GUIDE HAS BEEN SENT!

[IMG: Icon representing email updates or information sign up]

You will receive an email with your guide shortly. Be sure to take it with you to your next appointment with your doctor.

[IMG: Icon representing a healthcare provider]
Find a Specialist >>

[H3] You are now leaving VYNDAMAX.com
Links to other websites are provided as a convenience to the viewer. Pfizer accepts no responsibility for the content of linked sites.

[H3] You are now leaving VYNDAMAX.com
The information provided in this website is intended only for healthcare professionals in the United States.

[H3] Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.|t
8960 chars
SUB-PAGE (https://vyndaqel.com/financial-assistance/) Financial Assistance | VYNDAMAX® (tafamidis) | Safety Info 
[IMG: Actor portrayal of an older adult visiting the doctor]

Actor portrayal

[IMG: Actor portrayal of an older adult visiting the doctor]

[H2] Connect with a Patient Access Coordinator (PAC)

With a valid prescription, you can request support from a PAC–your dedicated partner in navigating the VYNDAMAX access process, they'll guide you every step of the way.
Your PAC will personally:
Help you understand your insurance coverage and benefits
Explain what to expect when working with a specialty pharmacy
Keep you informed with timely updates and actionable requirements

With a valid prescription, you can request support from a PAC–your dedicated partner in navigating the VYNDAMAX access process, they'll guide you every step of the way.
Your PAC will personally:
Help you understand your insurance coverage and benefits
Explain what to expect when working with a specialty pharmacy
Keep you informed with timely updates and actionable requirements

With a valid prescription, you can request support from a PAC–your dedicated partner in navigating the VYNDAMAX access process, they'll guide you every step of the way.
Your PAC will personally:
Help you understand your insurance coverage and benefits
Explain what to expect when working with a specialty pharmacy
Keep you informed with timely updates and actionable requirements

Connect with a PAC today at 1-888-863-1177 (Mon-Fri, 8AM - 7PM ET)

Request your PAC

[H2] Sometimes an insurance plan will ask for a reauthorization after some time on treatment
[H6] If that happens, you and your doctor can work together to give your insurance provider what they need, so you can continue VYNDAMAX.

[H2] Learn more about 2026 Medicare Part D changes
$2,100
is the annual out-of-pocket (OOP) cap for your covered Part D medicines. That means when you get your first VYNDAMAX prescription in 2026, you will reach the $2,100 OOP maximum. For the rest of the year, you will pay $0 for all your Part D prescription medications.

[H3] Download the Medicare Part D Flashcard to learn more about what’s new in 2026

[IMG: VYNDAMAX (tafamidis) patient medicare part D flashcard thumbnail]

Download
[IMG: Download icon]

[H4] VYNDAMAX Co-pay Savings Program
Eligible, commercially insured patients may pay as little as $0 a month*
*Limits, terms, and conditions apply. Click here for full terms and conditions.

[IMG: copay card]
Confirm eligibility

Frequently asked questions (FAQs) about VYNDAQEL® (tafamidis meglumine)

Will VYNDAQEL be available in 2026?

VYNDAMAX will be the only tafamidis option available after 2025. This decision is focused on patient convenience as VYNDAMAX offers the same active ingredient and clinical benefits as VYNDAQEL, but in just one pill once a day, making it easier for patients to take their prescription.

What do I do if I am currently taking VYNDAQEL?

If you are currently taking VYNDAQEL, talk to your healthcare provider about switching to VYNDAMAX, a more convenient dosing option for tafamidis.
A new prescription and prior authorization will likely be required to make the switch.
A Patient Access Coordinator (PAC) can help you understand the insurance approval process and answer questions about getting access to VYNDAMAX. Sign up here.

What is the difference between VYNDAQEL & VYNDAMAX?

There is no difference in how the medicines work, but VYNDAMAX offers more convenient dosing and will be the only tafamidis option available after 2025.
The difference is in how they’re taken: VYNDAMAX is one pill once a day, while VYNDAQEL requires four pills daily.

[IMG: VyndaLink logo, connecting access, reimbursement, and education]

[H2] VynAssist - your home for personalized access and reimbursement support for patients prescribed VYNDAMAX.
VynAssist is here to help with your VYNDAMAX prescription by offering:
Access support - Guide you through medication access
Financial assistance - Connect you with potential options to help manage costs
Support & resources - Inform you of options for personalized support and downloadable resources

Explore VynAssist today

Learn about patient support & advocacy

[H3] You are now leaving VYNDAMAX.com
Links to other websites are provided as a convenience to the viewer. Pfizer accepts no responsibility for the content of linked sites.

[H3] You are now leaving VYNDAMAX.com
The information provided in this website is intended only for healthcare professionals in the United States.

[H3] Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.|t
4958 chars
SUB-PAGE (https://vyndaqel.com/about-vyndamax/) How May VYNDAMAX® (tafamidis) Help ATTR-CM? | Safety Info 
[IMG: Actor portrayal of a family engaging in conversation at their daughter]

Actor portrayal

[IMG: Actor portrayal of a family engaging in conversation at their daughter]

[H2] VYNDAMAX helps people with transthyretin cardiac amyloidosis (ATTR-CM) live longer
VYNDAMAX* was studied in the “Tafamidis in Transthyretin Amyloidosis Cardiomyopathy Clinical Trial” (known as ATTR-ACT)
The study tested if VYNDAMAX could help people with ATTR-CM live longer and reduce hospitalizations due to heart problems compared to placebo
The study also tested the impact of VYNDAMAX on quality of life and ability to function
*The clinical studies of VYNDAQEL® (a different form of tafamidis) supported the approval of VYNDAMAX. Both drugs contain the same active ingredient.

How was VYNDAMAX studied?
The safety and efficacy of VYNDAMAX were studied in a 30-month clinical study of 441 adult patients with wild-type or hereditary ATTR-CM.
The VYNDAMAX study primarily focused on the reduction of death and heart-related hospitalizations, as well as safety
VYNDAMAX was also assessed on other aspects of ATTR-CM, including walking distance (6-Minute Walk Test) and health-related quality of life
Efficacy and safety were determined by comparing patients treated with VYNDAMAX (n=264), with patients who did not take VYNDAMAX (placebo) (n=177)
Patients were evaluated every 6 months for a total of 30 months

VYNDAMAX was proven to help people live longer

Survival rate at month 30
[IMG: 71% and 57%, used to compare VYNDAMAX (tafamidis) survival rate at month 30 for people on treatment and those on a placebo. See safety info.]
AFTER 21/2YEARS
more people were alive taking VYNDAMAX than placebo

[H2] VYNDAMAX was proven to reduce hospitalizations for heart problems

In the study, patients taking VYNDAMAX had fewer heart-related hospitalizations than those in the placebo group

32% LOWER RISK
of hospitalizations related to heart problems
[IMG: Ambulance in a downward pointing arrow used to communicate that the people that took VYNDAMAX (tafamidis) had 32% lower risk of heart related hospitalizations. See safety info.]

[H2] Health-related quality-of-life measures†
In a 2.5-year clinical study, compared to those not on treatment (placebo group), people taking VYNDAMAX reported:

[IMG: Checkmark icon]
[H3] Better quality of life
(mental health status, enjoyment of life)
[IMG: Checkmark icon]
[H3] Fewer heart-related symptoms
(shortness of breath, fatigue, swollen feet or ankles)
[IMG: Checkmark icon]
[H3] More comfort performing daily activities
(ability to perform social and physical activities)

†At the end of the 30-month study compared to people taking a placebo. The Kansas City Cardiomyopathy Questionnaire (KCCQ) was used to measure health-related quality of life. Patients in the VYNDAMAX and placebo groups had worse KCCQ overall summary scores at month 30 than at the start of the study.

[IMG: important]
While there's no cure today, VYNDAMAX slows down ATTR-CM

Remember that even if you don’t feel it working, always take VYNDAMAX as prescribed. It’s important to tell your doctor how you are feeling.

[H2] Heart function and exercise capacity were measured in patients taking VYNDAMAX
The 6-Minute Walk Test (6MWT) measured heart function and exercise capacity.
At 30 months, people who took VYNDAMAX were able to walk a significant 83 yards farther (almost the length of a football field) on average than people who did not take VYNDAMAX (placebo).‡
[IMG: Illustration depicting the 6 minute walk test, at the end of the clinical trial, people who took VYNDAMAX (tafamidis) were able to walk 83 yards more on average than people who took placebo. See safety info.]
‡Patients in the VYNDAMAX and placebo groups had worse 6-minute walking distance than at the start of the study.

[H3]
Watch how VYNDAMAX can help you

Create a discussion guide to help you log your symptoms and talk to your doctor about ATTR-CM

Get started

CARDIOLOGIST RECOMMENDED

[H2] VYNDAMAX is a treatment with a Class 1§ recommendation for ATTR-CM in guidelines from:
American College of Cardiology
American Heart Association
Heart Failure Society of America
§Class 1 guidelines are given when there’s strong evidence or general agreement that a treatment is beneficial, useful, and effective. The above recommendation is from the 2022 guidelines.

[H3] Hear from Stan, a real patient taking VYNDAMAX

“I was glad to find out that there is treatment available now…so that gave me some hope.”

[H3] Hear from Stan, a real patient taking VYNDAMAX

“I was glad to find out that there is treatment available now…so that gave me some hope.”

[H3] Hear from Stan, a real patient taking VYNDAMAX

“I was glad to find out that there is treatment available now…so that gave me some hope.”

“I was glad to find out that there is treatment available now…so that gave me some hope.”

[IMG: VyndaCares logo, a program that provides helpful information about ATTR-CM and VYNDAMAX (tafamidis)Vyndacares logo, a program that provides helpful information about ATTR-CM and VYNDAMAX (tafamidis). See safety info.]
Get to the heart of what matters

Stay informed with educational materials about ATTR-CM and VYNDAMAX

Sign up

Explore how VYNDAMAX works

[H3] You are now leaving VYNDAMAX.com
Links to other websites are provided as a convenience to the viewer. Pfizer accepts no responsibility for the content of linked sites.

[H3] You are now leaving VYNDAMAX.com
The information provided in this website is intended only for healthcare professionals in the United States.

[H3] Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.|t
6064 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
12Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 6 0
/jacks-journey/ 0 0
/financial-assistance/ 0 0
/about-vyndamax/ 6 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema 
[
    {
        "@context": "http://schema.org/",
        "@type": "MedicalWebPage",
        "specialty": "https://schema.org/Cardiovascular",
        "audience": "https://schema.org/Patient",
        "url": "https://www.vyndamax.com/",
        "headline": "VYNDAMAX® (tafamidis) Prescription Treatment for ATTR-CM | Safety Info",
        "description": "VYNDAMAX® is used to treat wild-type & hereditary forms of transthyretin amyloid cardiomyopathy (ATTR-CM) in adults. Learn more about the risks and benefits.",
        "image": {
            "@type": "ImageObject",
            "description": "VYNDAMAX (tafamidis) 61mg logo",
            "url": "https://www.vyndamax.com/profiles/pfvyndamaxcom_profile/themes/custom/vyndamax/vyndamax-tafamidis-logo.svg"
        },
        "about": [
            {
                "@type": "Drug",
                "name": "VYNDAMAX",
                "nonProprietaryName": "tafamidis",
                "image": {
                    "@type": "ImageObject",
                    "name": "VYNDAMAX® (tafamidis)",
                    "description": "VYNDAMAX (tafamidis) 61mg logo",
                    "contentUrl": "https://www.vyndamax.com/profiles/pfvyndamaxcom_profile/themes/custom/vyndamax/vyndamax-tafamidis-logo.svg"
                },
                "description": "VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.",
                "prescribingInfo": "http://labeling.pfizer.com/ShowLabeling.aspx?id=11685",
                "warning": "Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:\nhave liver problems.\nare pregnant or plan to become pregnant.\nare breastfeeding or plan to breastfeed.\nTell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.\nThere were no known side effects that happened during treatment with VYNDAMAX.",
                "dosageForm": "Capsule",
                "administrationRoute": [
                    "Swallow",
                    "oral"
                ],
                "doseSchedule": {
                    "@type": "DoseSchedule",
                    "frequency": "VYNDAMAX offers convenient once-daily dosing. A single 61-mg, once-daily capsule. A pill taken by mouth .It is important to continue taking VYNDAMAX as prescribed by your doctor. VYNDAMAX capsules should be swallowed whole and never crushed or cut. If you miss a dose, take it as soon as you remember. If it is time for your next dose, skip the missed dose and take the next dose at your regularly scheduled time. Do not take 2 doses at the same time."
                },
                "offers": {
                    "@type": "Offer",
                    "price": "0",
                    "priceCurrency": "USD",
                    "url": "https://www.vyndamax.com/financial-assistance"
                },
                "mechanismOfAction": "VYNDAMAX helps hold the TTR protein together. This can reduce the buildup of dangerous amyloid deposits in the heart and slow down ATTR-CM. ATTR-CM happens when a protein called transthyretin (TTR) breaks down and turns into amyloid. Amyloid can build up in the heart making it harder for the heart to pump effectively. The TTR protein is mostly made in the liver and in smaller amounts in the outer lining of the brain and retina.",
                "manufacturer": {
                    "@type": "Corporation",
                    "name": "Pfizer",
                    "logo": "https://www.pfizer.com/profiles/pfecpfizercomus_profile/themes/pfecpfizercomus/public/assets/images/logo-blue.svg"
                }
            }
        ]
    }
]
/jacks-journey/ — no schema detected (entity gap)
/financial-assistance/ — no schema detected (entity gap)
/about-vyndamax/ — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: VYNDAMAX (Pfizer) (vyndaqel.com)

https://vyndaqel.com 📍 Industry: Medical Devices, Pharma & Biotech
22 BS / 100

A rare example of a high-substance medical site where clinical data drives the narrative rather than marketing fluff. While it exhibits some regulatory ‘trust theatre’ regarding testimonials, its adherence to specific metrics and 2026 financial transparency makes it a benchmark for low-BS pharma communication.

Info Density Power-words vs. Substance ratio.
6
20% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
0
0% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
10
50% BS
Commodity Fingerprint Detection of industry clichés/templates.
5
33% BS
Identity & Authority Expert verifiability & Schema depth.
1
7% BS

Add an external link or specific citation source for the ‘#1 PRESCRIBED’ claim to move it from a marketing assertion to a verified fact. Implement Person schema for both Jack Nicklaus and Stan to anchor testimonials in structured data. Add a direct outbound link to the ClinicalTrials.gov (NCT number) registration for the ATTR-ACT study to provide a verified proof path beyond the site’s own copy.

The website perfectly aligns with the Medical Pharma and Biotech industry, specifically focusing on the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). The presence of complex safety information, clinical trial data (ATTR-ACT), and Medicare Part D 2026 projections confirms its authenticity as a pharmaceutical brand site.

“The score of 22 is primarily driven by the Trust Theatre pillar (10 points) due to the presence of unverified review counts and the lack of outbound proof links to independent trial databases. Minor points were added for the use of standard pharma templates and jargon (5 points) and patient repetition (6 points). The site scored perfectly in Semantic Coherence, showing no drift between claims and evidence.”

Verified Analysis Date: June 20, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution

This training module utilizes a snapshot of public data from VYNDAMAX (Pfizer), captured on June 20, 2026, to demonstrate how machine logic evaluates different types of business narratives.

Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.

Notice to VYNDAMAX (Pfizer): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.

Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.

To all users: You are encouraged to visit the live site at https://vyndaqel.com to view the most current version of its content and learn from the source what this company is about and what it offers.